Thursday, 25 April 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 25 April 2024
Listen to this story 
News

Pandemic expands shingles jab

Posted 21 October 2021 PM

The five-year catch-up program for MSD's shingles vaccine Zostavax has been extended for another two years with the Department of Health announcing those who missed or delayed vaccination due to the pandemic or other reasons now have until 31 October 2023 to get their free vaccination.

While vaccination against shingles with the Zostavax vaccine is free under the National Immunisation Program (NIP) for people aged 70, the five-year catch-up program for immunocompetent individuals aged 71-79 was due to expire on 1 November 2021.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (25)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (24)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.